Biotech Co.* (Symbol) | Agbiotech Partner (Country/Symbol) | Type/Product Area | Disclosed Funding (M) | Terms/Details (Date) |
Agritope Inc. (AGTO) | Rohm and Haas Co. (NYSE:ROH) | Technology development and marketing agreement to create a new plant transformation marker selection system for use in agricultural biotechnology | ND | Once developed, the system will permit the rapid creation of improved plant varieties; both companies will conduct research and any royalties will be shared equally; Rohm and Haas will manufacture the ligand and market the transformation marker system (9/14) |
Akkadix Corp.* | Pangene Corp.* | Licensing agreement for Pangene's Homologous Recombination and other related technologies | ND | Akkadix has been granted a license to technologies for commercial use in the plant science field; Pangene also has been granted a nonexclusive cross-license to Akkadix's bioinformatics technology (9/13) |
Akkadix Corp.* | Samuel Roberts Noble Foundation | Research project for improving the quality and digestibility of forage crops | ND | Initial target for the project is alfalfa; Akkadix will provide research support and its bioinformatics to identify genes in return for access to resulting developments (11/29) |
Aurora Biosciences Corp. (ABSC) | Ceres Inc.* | License agreement for Aurora's fluorescent protein technology for use in agricultural applications | ND | Ceres was granted nonexclusive rights to use the technology for in vitro and in vivo research and development activities and to provide services to third parties; the multi-year agreement includes an up-front technology access fee, annual license fees and royalties; Aurora also has an option to acquire equity in Ceres (10/3) |
Ceres Inc.* | The Institute for Genomic Research | Collaboration to identify the structure of genes and their encoded proteins in the chromosomes of a plant species | ND | Parties will focus on the plant species Arabidopsis thaliana (12/19) |
Dow AgroSciences LLC (subsidiary of Dow Chemical Co.; NYSE:DOW) | Boyce Thompson Institute for Plant Research | Multiyear research and collaboration agreement to evaluate and develop plant-derived veterinary biologics | ND | Dow and the Boyce Thompson Institute signed the agreement under which scientists will work to accelerate the development and commercialization of plant-derived vaccines for the animal health industry (11/2) |
Encore Technologies* | Prophyta* (Germany) | Exclusive distribution and marketing agreement for Contans WG | ND | Encore will distribute and market Contans WG, a biological fungicide, developed by Prophyta, which controls Sclerotinia diseases in the soil (11/13) |
EraGen Biosciences* | Novartis Agricultural Discovery Institute Inc. (NYSE:NVS) | Collaboration for high-throughput genotyping | ND | EraGen and Novartis will collaborate with Novartis to provide AEGIS (an expanded genetic information system) technology for genotyping; the goal is to accelerate the research and development of methods to protect and improve crops (11/2) |
Exelixis Inc. (EXEL) | Dow AgroSciences LLC (subsidiary of Dow Chemical Co.; NYSE:DOW) | Three-year collaboration to develop fungicides and herbicides for crop protection | ND | Exelixis will identify and validate targets and format screening assays that will be used by Dow; Dow will provide research funding, as well as milestone payments and royalties (7/11) |
GeneData AG* (Switzerland) | Zeneca Agrochemicals (unit of AstraZeneca plc; UK; NYSE:AZN) | License agreement for gene expression software | ND | Zeneca will use GeneData's GD Expressionist software for analysis of gene expression array data, supporting development of crop protection products, controlling principal weeds, pests and major crop diseases (8/8) |
Geron Corp. (GERN) | AviGenics Inc.* and Origen Therapeutics Inc.* | Licensing agreement for nuclear transfer technology | ND | AviGenics and Origen Therapeutics obtained option rights to license on a nonexclusive, worldwide basis Geron's nuclear transfer technology to generate cloned poultry; Geron will receive equity in each company; terms for the licenses include additional equity and a share in future revenues generated from products under the licenses (12/20) |
Oxford Molecular Group plc (UK; LSE:OMG) | Zeneca Agrochemicals (unit of AstraZeneca plc; UK; NYSE:AZN) | Software agreement | ND | Zeneca purchased Oxford's RS3 Discovery and Diamond Discovery software; companies will work together to develop an advanced combinatorial chemistry software system (8/10) |
Protherics plc (UK; LSE:PTI) | Zeneca Agrochemicals (unit of AstraZeneca plc; UK; NYSE:AZN) and Cytopia Pty Ltd.* (Australia) | Agreement for Protherics' Dock Crunch virtual screening service | US$.25 | Protherics will provide its services to both companies; the contracts are worth US$250,000 (11/1**) |
Rosetta Inpharmatics Inc. (RSTA) | Monsanto Co. (NYSE:MON) | Converted pilot agreement to a full-scale, three-year collaboration to develop better crops | $15 | Monsanto will pay Rosetta $15M over three years for the delivery of gene expression information; Rosetta has the potential to receive future payments, including royalties (11/28) |
Notes: | ||||
This chart contains information on new corporate agreements in agricultural biotechnology covering the time between 7/1/00 and 12/20/00; stocks trade on Nasdaq unless otherwise noted. | ||||
AMEX = American Stock Exchange; LSE = London Stock Exchange | ||||
ND = Not disclosed, reported and/or available | ||||
* Private companies are indicated with an asterisk. | ||||
** Denotes the date the item ran in BioWorld International | ||||
